Cargando…
Neuropsychiatric events associated with montelukast in patients with asthma: a systematic review
BACKGROUND: The United States Food and Drug Administration issued a black box warning on the mental health adverse effects of montelukast in 2020. Age-related effects on the risk of developing specific neuropsychiatric events in montelukast users remain largely unknown. OBJECTIVE: To describe the ri...
Autores principales: | Lo, Chris Wai Hang, Pathadka, Swathi, Qin, Simon Xiwen, Fung, Lydia W.Y., Yan, Vincent Ka Chun, Yiu, Hei Hang Edmund, Bloom, Chloe I., Wong, Ian Chi Kei, Chan, Esther Wai Yin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10523155/ https://www.ncbi.nlm.nih.gov/pubmed/37758273 http://dx.doi.org/10.1183/16000617.0079-2023 |
Ejemplares similares
-
Evaluation of Neuropsychiatric Effects of Montelukast–Levocetirizine Combination Therapy in Children with Asthma and Allergic Rhinitis
por: Altaş, Uğur, et al.
Publicado: (2023) -
Analysis of Neuropsychiatric Diagnoses After Montelukast Initiation
por: Paljarvi, Tapio, et al.
Publicado: (2022) -
Neuropsychiatric Adverse Events of Montelukast: An Analysis of Real-World Datasets and drug−gene Interaction Network
por: Umetsu, Ryogo, et al.
Publicado: (2021) -
Meta-analysis of the relationship between montelukast use and neuropsychiatric events in patients with allergic airway disease
por: Mou, Yakui, et al.
Publicado: (2023) -
Montelukast: its role in the treatment of childhood asthma
por: Harmanci, Koray
Publicado: (2007)